Abstract
This letter describes the preparation of quinoline derivatives and their cytotoxic potentials toward human carcinoma cell lines. Among the selected compounds, 8-hydroxy-2-quinolinecarbaldehyde (3) showed the best in vitro cytotoxicity against the human cancer cell lines, including MDA231, T-47D, Hs578t, SaoS2, K562, SKHep1 (with a MTS50range of 12.5-25 μg/mL) and Hep3B (with a MTS50range of 6.25±0.034 μg/mL). The in vivo antitumor activity of compound 3 on subcutenaous Hep3B hepatocellular carcinoma xenograft in athymic nude mice was then studied. The results showed that the dose of 10 mg/kg/day of compound 3 with intraperitoneal injection for 9 days totally abolished the growth of the xenograft tumor of Hep3B with no histological damage on vital organs as compared with the control. The experimental results suggested that compound 3 has a good potential as an antitumor agent.
| Original language | English |
|---|---|
| Pages (from-to) | 170-174 |
| Number of pages | 5 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 14 Feb 2013 |
Keywords
- 8-hydroxy-2-quinolinecarbaldehyde
- antitumor
- hepatocellular carcinoma
- quinoline derivatives
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry